General Oncology, Inc.

Form D Filings

Location
Brookline, MA
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001658021
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
7/2/2025 Equity, Option to Acquire $3,675,587 $10,879,308 $17,325,000 $6,445,692 6/25/2019 7/2/2025 D/A 000165802125000002
7/2/2024 Equity $1,175,000 $7,203,721 $11,250,000 $4,046,279 6/25/2019 7/2/2024 D/A 000165802124000001
12/21/2023 Equity $2,825,000 $6,028,721 $7,500,000 $1,471,279 6/25/2019 12/20/2023 D/A 000165802123000001
12/22/2022 Equity $0 $3,203,721 $7,500,000 $4,296,279 6/25/2019 12/22/2022 D/A 000165802122000002
11/10/2022 Equity $898,721 $3,203,721 $3,750,000 $546,279 6/25/2019 11/10/2022 D/A 000165802122000001
11/10/2021 Equity $876,250 $2,305,000 $3,750,000 $1,445,000 6/25/2019 11/9/2021 D/A 000165802121000002
12/23/2020 Equity $698,750 $1,428,750 $2,500,000 $1,071,250 6/25/2019 12/23/2020 D/A 000165802120000002
7/14/2020 Equity $285,000 $730,000 $1,250,000 $520,000 6/25/2019 7/10/2020 D/A 000165802120000001
7/9/2019 Equity $445,000 $445,000 $1,250,000 $805,000 6/25/2019 7/9/2019 D 000165802119000001
9/5/2017 Equity $3,463,000 $34,803,641 $46,905,641 $12,102,000 11/2/2015 9/5/2017 D/A 000165802117000001
11/16/2015 Equity $31,340,641 $31,340,641 $46,905,641 $15,565,000 11/2/2015 11/16/2015 D 000165802115000001